277 related articles for article (PubMed ID: 24333557)
1. Ascorbyl palmitate/DSPE-PEG nanocarriers for oral iron delivery: preparation, characterisation and in vitro evaluation.
Zariwala MG; Farnaud S; Merchant Z; Somavarapu S; Renshaw D
Colloids Surf B Biointerfaces; 2014 Mar; 115():86-92. PubMed ID: 24333557
[TBL] [Abstract][Full Text] [Related]
2. A novel approach to oral iron delivery using ferrous sulphate loaded solid lipid nanoparticles.
Zariwala MG; Elsaid N; Jackson TL; Corral López F; Farnaud S; Somavarapu S; Renshaw D
Int J Pharm; 2013 Nov; 456(2):400-7. PubMed ID: 24012860
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
[TBL] [Abstract][Full Text] [Related]
4. Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs.
Moribe K; Maruyama S; Inoue Y; Suzuki T; Fukami T; Tomono K; Higashi K; Tozuka Y; Yamamoto K
Int J Pharm; 2010 Mar; 387(1-2):236-43. PubMed ID: 20005934
[TBL] [Abstract][Full Text] [Related]
5. Composition-dependent structural changes and antitumor activity of ASC-DP/DSPE-PEG nanoparticles.
Higashi K; Mibu F; Saito K; Limwikrant W; Yamamoto K; Moribe K
Eur J Pharm Sci; 2017 Mar; 99():24-31. PubMed ID: 27916697
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
Chandran T; Katragadda U; Teng Q; Tan C
Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305
[TBL] [Abstract][Full Text] [Related]
7. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
8. Ascorbyl palmitate-loaded chitosan nanoparticles: characteristic and polyphenol oxidase inhibitory activity.
Kim MK; Lee JS; Kim KY; Lee HG
Colloids Surf B Biointerfaces; 2013 Mar; 103():391-4. PubMed ID: 23247266
[TBL] [Abstract][Full Text] [Related]
9. DSPE-PEG: a distinctive component in drug delivery system.
Che J; Okeke CI; Hu ZB; Xu J
Curr Pharm Des; 2015; 21(12):1598-605. PubMed ID: 25594410
[TBL] [Abstract][Full Text] [Related]
10. Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery.
Elsaid Z; Taylor KM; Puri S; Eberlein CA; Al-Jamal K; Bai J; Klippstein R; Wang JT; Forbes B; Chana J; Somavarapu S
Eur J Pharm Sci; 2017 Apr; 101():228-242. PubMed ID: 28163163
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol-poly(ethylene) glycol nanocarriers for the transscleral delivery of sirolimus.
Elsaid N; Somavarapu S; Jackson TL
Exp Eye Res; 2014 Apr; 121():121-9. PubMed ID: 24530465
[TBL] [Abstract][Full Text] [Related]
12. Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids.
Craparo EF; Teresi G; Bondi' ML; Licciardi M; Cavallaro G
Int J Pharm; 2011 Mar; 406(1-2):135-44. PubMed ID: 21185363
[TBL] [Abstract][Full Text] [Related]
13. Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers.
Salmaso S; Pappalardo JS; Sawant RR; Musacchio T; Rockwell K; Caliceti P; Torchilin VP
Bioconjug Chem; 2009 Dec; 20(12):2348-55. PubMed ID: 19928843
[TBL] [Abstract][Full Text] [Related]
14. Development of chitosan-based nanoparticles through inter-polymeric complexation for oral drug delivery.
Jana S; Maji N; Nayak AK; Sen KK; Basu SK
Carbohydr Polym; 2013 Oct; 98(1):870-6. PubMed ID: 23987423
[TBL] [Abstract][Full Text] [Related]
15. The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate.
Zhang J; Chen Y; Li X; Liang X; Luo X
Int J Nanomedicine; 2016; 11():4187-97. PubMed ID: 27616886
[TBL] [Abstract][Full Text] [Related]
16. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration.
Sezgin Z; Yuksel N; Baykara T
Int J Pharm; 2007 Mar; 332(1-2):161-7. PubMed ID: 17055200
[TBL] [Abstract][Full Text] [Related]
17. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
Giovino C; Ayensu I; Tetteh J; Boateng JS
Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
[TBL] [Abstract][Full Text] [Related]
18. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
19. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
Pawar H; Douroumis D; Boateng JS
Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
[TBL] [Abstract][Full Text] [Related]
20. Optimization of PEGylated nanoemulsions for improved pharmacokinetics of BCS class II compounds.
Devalapally H; Zhou F; McDade J; Goloverda G; Owen A; Hidalgo IJ; Silchenko S
Drug Deliv; 2015; 22(4):467-74. PubMed ID: 24344786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
